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Periodontitis is a chronic inflammatory disease induced by anaerobic bacteria. It is affecting 
tooth supporting tissues and without proper treatment it may lead to tooth loss. 
Oral administration of antibiotics may not provide adequate drug levels in the periodontal 
pockets to eliminate microorganisms and could also lead to serious side effects, while the 
administration of local delivery systems containing antibiotics could help eliminate the 
disease [1]. 
The aim of the present work was to develop a swellable, biodegradable, biocompatible, 
mucoadhesive lipid-based local delivery systems containing antibiotics for the treatment of 
periodontal disease. 
Lipid-based systems may be able to protect the active ingredients from environmental 
hazards; thus decomposition, while providing sustained release. Incorporated polymers may 
help the swelling and degradation; therefore, the drug release and the elimination of the 
delivery systems [1]. 
During the formulation period, different methods were used to determine the optimal 
composition of the lipid formulations. DSC, consistency, wettability, swelling and degradation, 
drug release measurements and an antimicrobial study were carried out. 
Results of the different measurements and investigations show that formulations with optimal 
composition could provide sustained drug release and a long-lasting antimicrobial effect 
against periodonthopathogenic bacteria. 
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